Note: Ingredients listed on restricted chemical lists
EC/CAS
270-325-2/68424-85-1
Name of the chemical
Alkyl (C12-16) dimethylbenzyl ammonium chloride
Concentration
5 - 10
EC/CAS
230-525-2/7173-51-5
Name of the chemical
Didecyldimethylammonium chloride
Concentration
0.5 - 1
General Information
Version
3.01
Revision date
2023-05-03
Product name
Kenocid 210 D/Bio Des
1.2.1 Relevant identified uses
Professional use
Icons in SDS
Company Information
company name
CID LINES N.V
e-mail address of the competent person responsible for the Safety Data Sheet
sds@cidlines.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H290, H314, H318, H400, H410, H411
Hazard statements
Code
Statements
H290
May be corrosive to metals
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS09
Signal word
Danger
Contains
Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides; Didecyldimethylammonium chloride
Hazard statements
H290 - May be corrosive to metals. H314 - Causes severe skin burns and eye damage. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water . P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER/doctor.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %